Company Name: WAVE Life Sciences Ltd.
WAVE Life Sciences Ltd. is a preclinical biopharmaceutical company. The company is engaged in the development of stereopure nucleic acid therapeutic candidates using its proprietary synthetic chemistry drug development platform. The company’s most advanced programs target:
- Duchenne muscular dystrophy
- Huntington’s disease
- Inflammatory bowel disease
Ticker Symbol: WVE (NASDAQ)
Company Website: www.wavelifesciences.com
Headquarters: Singapore; Cambridge, MA